Literature DB >> 18829759

Absence of replication of porcine endogenous retrovirus and porcine lymphotropic herpesvirus type 1 with prolonged pig cell microchimerism after pig-to-baboon xenotransplantation.

Nicolas C Issa1, Robert A Wilkinson, Adam Griesemer, David K C Cooper, Kazuhiko Yamada, David H Sachs, Jay A Fishman.   

Abstract

Porcine endogenous retrovirus (PERV), porcine cytomegalovirus (PCMV), and porcine lymphotropic herpesvirus (PLHV) are common porcine viruses that may be activated with immunosuppression for xenotransplantation. Studies of viral replication or transmission are possible due to prolonged survival of xenografts in baboon recipients from human decay-accelerating factor transgenic or alpha-1,3-galactosyltransferase gene knockout miniature swine. Ten baboons underwent xenotransplantation with transgenic pig organs. Graft survival was 32 to 179 days. Recipient serial samples of peripheral blood mononuclear cells (PBMC) and plasma were analyzed for PCMV, PERV, and PLHV-1 nucleic acids and viral replication using quantitative PCR assays. The PBMC contained PERV proviral DNA in 10 animals, PLHV-1 DNA in 6, and PCMV in 2. PERV RNA was not detected in any PBMC or serum samples. Plasma PLHV-1 DNA was detected in one animal. Pig cell microchimerism (pig major histocompatibility complex class I and pig mitochondrial cytochrome c oxidase subunit II sequences) was present in all recipients with detectable PERV or PLHV-1 (85.5%). Productive infection of PERV or PLHV-1 could not be demonstrated. The PLHV-1 viral load did not increase in serum over time, despite prolonged graft survival and pig cell microchimerism. There was no association of viral loads with the nature of exogenous immune suppression. In conclusion, PERV provirus and PLHV-1 DNA were detected in baboons following porcine xenotransplantation. Viral detection appeared to be due to persistent pig cell microchimerism. There was no evidence of productive infection in recipient baboons for up to 6 months of xenograft function.

Entities:  

Mesh:

Year:  2008        PMID: 18829759      PMCID: PMC2593320          DOI: 10.1128/JVI.01278-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Long-term monitoring of xenotransplanted baboons: no evidence for pig endogenous retrovirus transmission.

Authors:  C Templin; C Schröder; A R Simon; G Laaff; J Köhl; M Chikobava; B Lapin; M E Winkler; K Wiebe; G Steinhoff; U Martin
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

2.  Infection of nonhuman primate cells by pig endogenous retrovirus.

Authors:  J H Blusch; C Patience; Y Takeuchi; C Templin; C Roos; K Von Der Helm; G Steinhoff; U Martin
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

3.  Detection and characterization of porcine endogenous retrovirus in porcine plasma and porcine factor VIII.

Authors:  D M Takefman; S Wong; T Maudru; K Peden; C A Wilson
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  Porcine endogenous retroviruses: in vitro host range and attempts to establish small animal models.

Authors:  Volker Specke; Stefan J Tacke; Klaus Boller; Jochen Schwendemann; Joachim Denner
Journal:  J Gen Virol       Date:  2001-04       Impact factor: 3.891

5.  Identification of novel porcine endogenous betaretrovirus sequences in miniature swine.

Authors:  T Ericsson; B Oldmixon; J Blomberg; M Rosa; C Patience; G Andersson
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  Multiple groups of novel retroviral genomes in pigs and related species.

Authors:  C Patience; W M Switzer; Y Takeuchi; D J Griffiths; M E Goward; W Heneine; J P Stoye; R A Weiss
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  Posttransplantation lymphoproliferative disease in miniature swine after allogeneic hematopoietic cell transplantation: similarity to human PTLD and association with a porcine gammaherpesvirus.

Authors:  C A Huang; Y Fuchimoto; Z L Gleit; T Ericsson; A Griesemer; R Scheier-Dolberg; E Melendy; H Kitamura; J A Fishman; J A Ferry; N L Harris; C Patience; D H Sachs
Journal:  Blood       Date:  2001-03-01       Impact factor: 22.113

8.  Expression of porcine endogenous retrovirus in peripheral blood leukocytes from ten different breeds.

Authors:  H Jin; Y Inoshima; D Wu; A Morooka; H Sentsui
Journal:  Transpl Infect Dis       Date:  2000-03       Impact factor: 2.228

9.  No evidence for infection of human cells with porcine endogenous retrovirus (PERV) after exposure to porcine fetal neuronal cells.

Authors:  J H Dinsmore; C Manhart; R Raineri; D B Jacoby; A Moore
Journal:  Transplantation       Date:  2000-11-15       Impact factor: 4.939

10.  No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys.

Authors:  C Patience; G S Patton; Y Takeuchi; R A Weiss; M O McClure; L Rydberg; M E Breimer
Journal:  Lancet       Date:  1998-08-29       Impact factor: 79.321

View more
  13 in total

1.  Retroviral restriction factors and infectious risk in xenotransplantation.

Authors:  Y Meije; R R Tönjes; J A Fishman
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

2.  Absence of interaction between porcine endogenous retrovirus and porcine cytomegalovirus in pig-to-baboon renal xenotransplantation in vivo.

Authors:  Jay A Fishman; David H Sachs; Kazuhiko Yamada; Robert A Wilkinson
Journal:  Xenotransplantation       Date:  2018-04-06       Impact factor: 3.907

3.  Results of gal-knockout porcine thymokidney xenografts.

Authors:  A D Griesemer; A Hirakata; A Shimizu; S Moran; A Tena; H Iwaki; Y Ishikawa; P Schule; J S Arn; S C Robson; J A Fishman; M Sykes; D H Sachs; K Yamada
Journal:  Am J Transplant       Date:  2009-10-21       Impact factor: 8.086

4.  Long-term safety from transmission of porcine endogenous retrovirus after pig-to-non-human primate corneal transplantation.

Authors:  Hyuk Jin Choi; Jiyeon Kim; Jae Young Kim; Hyun Ju Lee; Won Ryang Wee; Mee Kum Kim; Eung Soo Hwang
Journal:  Xenotransplantation       Date:  2017-05-14       Impact factor: 3.907

5.  Xenotransplantation-associated infectious risk: a WHO consultation.

Authors:  Jay A Fishman; Linda Scobie; Yasuhiro Takeuchi
Journal:  Xenotransplantation       Date:  2012 Mar-Apr       Impact factor: 3.907

6.  Development of a consensus protocol to quantify primate anti-non-Gal xenoreactive antibodies using pig aortic endothelial cells.

Authors:  Agnes M Azimzadeh; Guerard W Byrne; Mohamed Ezzelarab; Emily Welty; Gheorghe Braileanu; Xiangfei Cheng; Simon C Robson; Christopher G A McGregor; David K C Cooper; Richard N Pierson
Journal:  Xenotransplantation       Date:  2014-09-01       Impact factor: 3.907

Review 7.  Xenotransplantation: immunological hurdles and progress toward tolerance.

Authors:  Adam Griesemer; Kazuhiko Yamada; Megan Sykes
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

8.  Susceptibility of porcine endogenous retrovirus to anti-retroviral inhibitors.

Authors:  Takele Argaw; Winston Colon-Moran; Carolyn Wilson
Journal:  Xenotransplantation       Date:  2016-03-29       Impact factor: 3.907

Review 9.  Porcine Lymphotropic Herpesviruses (PLHVs) and Xenotranplantation.

Authors:  Joachim Denner
Journal:  Viruses       Date:  2021-06-04       Impact factor: 5.048

Review 10.  Why was PERV not transmitted during preclinical and clinical xenotransplantation trials and after inoculation of animals?

Authors:  Joachim Denner
Journal:  Retrovirology       Date:  2018-04-02       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.